Published in Neoplasia on March 06, 2001
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A (2003) 3.72
Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis (2003) 2.90
Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc Natl Acad Sci U S A (2005) 2.54
Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Res (2005) 2.18
Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A (2002) 1.93
Luciferase imaging of a neurotropic viral infection in intact animals. J Virol (2003) 1.83
Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res (2004) 1.67
Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging. Clin Exp Metastasis (2006) 1.64
Bioluminescence imaging. Proc Am Thorac Soc (2005) 1.61
An in vivo mouse model for human prostate cancer metastasis. Neoplasia (2008) 1.54
Molecular-genetic imaging: current and future perspectives. J Clin Invest (2003) 1.49
Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission. Eur J Nucl Med Mol Imaging (2008) 1.46
CREB is a critical regulator of normal hematopoiesis and leukemogenesis. Blood (2007) 1.39
In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer. Clin Exp Metastasis (2003) 1.37
Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging. J Nucl Med (2008) 1.35
In vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animals. Sensors (Basel) (2010) 1.33
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging. Mol Ther (2006) 1.32
Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI. FASEB J (2008) 1.26
A human brainstem glioma xenograft model enabled for bioluminescence imaging. J Neurooncol (2009) 1.26
Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging. Cancers (Basel) (2010) 1.24
Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy. BMC Cancer (2012) 1.22
Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling. Neoplasia (2008) 1.21
In vivo bioluminescence for tracking cell fate and function. Am J Physiol Heart Circ Physiol (2011) 1.20
Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice. PLoS One (2009) 1.18
Imaging in neurooncology. NeuroRx (2005) 1.14
PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model. Brain Res (2008) 1.11
Bioluminescent imaging of melanoma in live mice. J Invest Dermatol (2005) 1.08
GAS6 receptor status is associated with dormancy and bone metastatic tumor formation. PLoS One (2013) 1.06
Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: a novel model for dual modality longitudinal imaging of tumorigenesis in liver. J Hepatol (2010) 1.04
Targeting mRNA stability arrests inflammatory bone loss. Mol Ther (2008) 1.04
Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions. Prostate (2008) 1.03
Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression. J Exp Med (2010) 1.03
Bioluminescence imaging of leukemia cell lines in vitro and in mouse xenografts: effects of monoclonal and polyclonal cell populations on intensity and kinetics of photon emission. J Hematol Oncol (2013) 1.03
In vivo bioluminescence imaging of furin activity in breast cancer cells using bioluminogenic substrates. Bioconjug Chem (2009) 1.02
Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach. Mol Imaging (2005) 1.01
Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer. Mol Cancer Ther (2014) 1.01
Boosting bioluminescence neuroimaging: an optimized protocol for brain studies. PLoS One (2013) 1.01
In vivo bioluminescence tomography with a blocking-off finite-difference SP3 method and MRI/CT coregistration. Med Phys (2010) 0.97
Temporal variations of skin pigmentation in C57BL/6 mice affect optical bioluminescence quantitation. Mol Imaging Biol (2011) 0.96
Near infrared photoimmunotherapy in the treatment of pleural disseminated NSCLC: preclinical experience. Theranostics (2015) 0.95
DNA nanoparticles: detection of long-term transgene activity in brain using bioluminescence imaging. Mol Imaging (2011) 0.95
Measuring brain tumor growth: combined bioluminescence imaging-magnetic resonance imaging strategy. Mol Imaging (2009) 0.94
Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma. Mol Pharmacol (2009) 0.94
Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy. Mol Ther (2003) 0.94
In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice. Clin Exp Metastasis (2012) 0.92
The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model. Biochem Biophys Res Commun (2008) 0.92
A comparison of imaging techniques to monitor tumor growth and cancer progression in living animals. Int J Mol Imaging (2011) 0.92
Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy. Cancer Res (2010) 0.91
Assessing siRNA pharmacodynamics in a luciferase-expressing mouse. Mol Ther (2008) 0.91
Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer. Oncotarget (2015) 0.90
Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin. PLoS One (2012) 0.90
In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals. Eur J Nucl Med Mol Imaging (2006) 0.89
Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging. Eur J Nucl Med Mol Imaging (2007) 0.88
Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model. Transl Oncol (2011) 0.88
Near infrared photoimmunotherapy for lung metastases. Cancer Lett (2015) 0.88
An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging. PLoS One (2015) 0.87
Imaging bone morphogenetic protein 7 induced cell cycle arrest in experimental gliomas. Neoplasia (2011) 0.87
Novel molecular imaging platform for monitoring oncological kinases. Cancer Cell Int (2010) 0.87
A method to rapidly and accurately compare the relative efficacies of non-invasive imaging reporter genes in a mouse model and its application to luciferase reporters. Mol Imaging Biol (2012) 0.86
Imaging tumour cell heterogeneity following cell transplantation into optically clear immune-deficient zebrafish. Nat Commun (2016) 0.85
Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy. Mol Cancer (2009) 0.85
A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging. Nat Commun (2016) 0.85
Potential targets for molecular imaging of apoptosis resistance in hepatocellular carcinoma. Biomed Imaging Interv J (2011) 0.84
In vivo bioluminescence imaging of locally disseminated colon carcinoma in rats. Br J Cancer (2004) 0.84
Longitudinal imaging of cancer cell metastases in two preclinical models: a correlation of noninvasive imaging to histopathology. Int J Mol Imaging (2014) 0.84
Targeting and in vivo imaging of non-small-cell lung cancer using nebulized multimodal contrast agents. Proc Natl Acad Sci U S A (2014) 0.83
Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model. Oncotarget (2015) 0.83
A novel bioluminescence orthotopic mouse model for advanced lung cancer. Radiat Res (2011) 0.82
Bioluminescence imaging of invasive intracranial xenografts: implications for translational research and targeted therapeutics of brain tumors. Neurosurg Rev (2010) 0.81
Activation of iCaspase-9 in neovessels inhibits oral tumor progression. J Dent Res (2006) 0.81
Gene expression and gene therapy imaging. Eur Radiol (2006) 0.81
Intravenous KITENIN shRNA injection suppresses hepatic metastasis and recurrence of colon cancer in an orthotopic mouse model. J Korean Med Sci (2011) 0.80
An experimental brainstem tumor model using in vivo bioluminescence imaging in rat. Childs Nerv Syst (2009) 0.79
Novel split-luciferase-based genetically encoded biosensors for noninvasive visualization of Rho GTPases. PLoS One (2013) 0.78
The Expanding Toolbox of In Vivo Bioluminescent Imaging. Front Oncol (2016) 0.77
Targeting Orthotopic Glioma in Mice with Genetically Engineered Salmonella typhimurium. J Korean Neurosurg Soc (2014) 0.77
Bioluminescence imaging of therapy response does not correlate with FDG-PET response in a mouse model of Burkitt lymphoma. Am J Nucl Med Mol Imaging (2012) 0.76
The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model. Invest New Drugs (2010) 0.76
An enhanced chimeric firefly luciferase-inspired enzyme for ATP detection and bioluminescence reporter and imaging applications. Anal Biochem (2015) 0.76
The use of high-frequency ultrasound imaging and biofluorescence for in vivo evaluation of gene therapy vectors. BMC Med Imaging (2013) 0.76
In Vivo Follow-up of Brain Tumor Growth via Bioluminescence Imaging and Fluorescence Tomography. Int J Mol Sci (2016) 0.75
Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer. Mol Cancer Ther (2016) 0.75
Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro. PLoS One (2015) 0.75
Quantitative, noninvasive, in vivo longitudinal monitoring of gene expression in the brain by co-AAV transduction with a PET reporter gene. Mol Ther Methods Clin Dev (2014) 0.75
Co-Registration of Bioluminescence Tomography, Computed Tomography, and Magnetic Resonance Imaging for Multimodal In Vivo Stem Cell Tracking. Tomography (2016) 0.75
A generalized hybrid algorithm for bioluminescence tomography. Biomed Opt Express (2013) 0.75
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models. J Vis Exp (2016) 0.75
Accounting for filter bandwidth improves the quantitative accuracy of bioluminescence tomography. J Biomed Opt (2015) 0.75
Longitudinal microcomputed tomography-derived biomarkers for lung metastasis detection in a syngeneic mouse model: added value to bioluminescence imaging. Lab Invest (2016) 0.75
Continuous, real-time bioimaging of chemical bioavailability and toxicology using autonomously bioluminescent human cell lines. Proc SPIE Int Soc Opt Eng (2013) 0.75
Molecular neuroimaging: the basics. Semin Roentgenol (2013) 0.75
Comprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imaging. PLoS One (2014) 0.75
Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol (1997) 3.47
Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia (2000) 2.84
Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev (1999) 2.83
Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A (1999) 2.76
Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia (1999) 2.16
Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci U S A (1998) 1.91
Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev (1994) 1.69
Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst (1994) 1.37
In vivo 31P and 2H NMR [corrected] studies of rat brain tumor pH and blood flow during acute hyperglycemia: differential effects between subcutaneous and intracerebral locations. Magn Reson Med (1989) 1.03
The use of animal models in cancer drug discovery and development. Stem Cells (1994) 1.01
Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet (1997) 13.64
Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem (1995) 9.56
Gluconeogenesis in the perfused rat liver. Biochem J (1966) 8.58
Successful use of sugammadex in a 'can't ventilate' scenario. Anaesthesia (2013) 5.21
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst (2000) 5.14
The epidemic behavior of the hepatitis C virus. Science (2001) 4.81
Bioluminescent indicators in living mammals. Nat Med (1998) 4.71
Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? Nature (1984) 4.70
Origin of mink cytopathic focus-forming (MCF) viruses:comparison with ecotropic and xenotropic murine leukemia virus genomes. Virology (1981) 4.62
Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol (2000) 4.44
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature (1995) 4.42
Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proc Natl Acad Sci U S A (1987) 4.31
A voltage-gated potassium channel in human T lymphocytes. J Physiol (1985) 4.16
Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40
Avoiding premature coronary deaths in Asians in Britain. BMJ (1995) 3.25
The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. Proc Natl Acad Sci U S A (1999) 3.06
Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. N Engl J Med (1981) 3.00
Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res (1997) 2.96
Signal transduction within the nucleus by mitogen-activated protein kinase. J Biol Chem (1992) 2.93
Visualizing the kinetics of tumor-cell clearance in living animals. Proc Natl Acad Sci U S A (1999) 2.76
Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J Infect Dis (1992) 2.75
Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science (1995) 2.74
Chlamydia pneumoniae and coronary heart disease. BMJ (1997) 2.73
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology (2001) 2.71
Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet (2000) 2.66
Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes. J Neurosci (1996) 2.65
Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med (1993) 2.59
Voltage-gated potassium channels are required for human T lymphocyte activation. J Exp Med (1984) 2.54
A population-based eye survey of older adults in a rural district of Rajasthan: I. Central vision impairment, blindness, and cataract surgery. Ophthalmology (2001) 2.51
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci U S A (2000) 2.49
Metabolic activities of the isolated perfused rat kidney. Biochem J (1967) 2.41
A cell culture model of the blood-brain barrier. J Cell Biol (1991) 2.35
Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther (1994) 2.28
Ophthalmic manifestations of acute leukaemias: the ophthalmologist's role. Eye (Lond) (2004) 2.27
Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases. Arthritis Rheum (2000) 2.26
Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature (1994) 2.24
The significance of sexual partner contact networks for the transmission dynamics of HIV. J Acquir Immune Defic Syndr (1990) 2.20
Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology (1995) 2.20
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci U S A (1995) 2.19
Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A (1991) 2.19
Ultra-fast three dimensional imaging of hyperpolarized 13C in vivo. MAGMA (2005) 2.17
Monoclonal antibody analysis of human T lymphocyte subpopulations exhibiting autologous mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1981) 2.16
Introduction of community-based skin-to-skin care in rural Uttar Pradesh, India. J Perinatol (2006) 2.16
Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia (1999) 2.16
Severe nutritional deficiencies in toddlers resulting from health food milk alternatives. Pediatrics (2001) 2.15
Hypernatraemia: why bother weighing breast fed babies? Arch Dis Child Fetal Neonatal Ed (2001) 2.13
A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J Biol Chem (1991) 2.13
Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science (1991) 2.11
Carbohydrate metabolism of the perfused rat liver. Biochem J (1967) 2.08
Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology (1992) 2.07
Inadequate ventilation with the LMA ProSeal. Anaesthesia (2003) 2.04
Radiation induced carotid artery blow out: a case report. Acta Chir Belg (1994) 2.03
Globe rupture during digital massage after peribulbar anesthesia. J Cataract Refract Surg (1997) 2.03
Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy. J Infect Dis (1998) 1.99
Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem (1997) 1.99
Role of contractile microfilaments in the release of histamine from mast cells. Nature (1972) 1.99
Infectious disease dynamics: What characterizes a successful invader? Philos Trans R Soc Lond B Biol Sci (2001) 1.99
Is schizophrenia disappearing? Lancet (1990) 1.98
Phenotypic and clinical manifestations of compound heterozygous genetic haemochromatosis (CHGH): a non-invasive approach to clinical management. Intern Med J (2013) 1.98
Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method. J Clin Microbiol (1995) 1.96
Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. Mol Cell Biol (2000) 1.93
Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci U S A (1998) 1.91
Rosette formation with mouse erythrocytes: probable marker for human B lymphocytes. Int Arch Allergy Appl Immunol (1975) 1.89
3-D FLASH imaging using a single surface coil and a new adiabatic pulse, BIR-4. Invest Radiol (1990) 1.88
Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis (2013) 1.88
Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin Exp Immunol (1976) 1.87
Acute small-bowel obstruction following mesenteric perforation by CAPD catheter. Nephrol Dial Transplant (1997) 1.85
Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis (1988) 1.83
Association between smoking and blood pressure: evidence from the health survey for England. Hypertension (2001) 1.82
Sodium reabsorption in the perfused rat kidney. Am J Physiol (1973) 1.82
Brief report: organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med (1994) 1.81
Congenital pouch colon in females. Pediatr Surg Int (1999) 1.81
Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation. Cell Immunol (1977) 1.76
Compilation of small RNA sequences, 1990. Nucleic Acids Res (1990) 1.76
Mineralogy of a mudstone at Yellowknife Bay, Gale crater, Mars. Science (2013) 1.75
Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Transpl Infect Dis (2006) 1.74
Martian fluvial conglomerates at Gale crater. Science (2013) 1.74
Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A (1999) 1.72
Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia (2000) 1.72
Ontogeny of lymphocyte subpopulations in human fetal liver. Proc Natl Acad Sci U S A (1976) 1.71
A population-based eye survey of older adults in a rural district of Rajasthan: II. Outcomes of cataract surgery. Ophthalmology (2001) 1.70
Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients. Clin Exp Immunol (1977) 1.69
Clinical predictors and radiological reliability in atlantoaxial subluxation in Down's syndrome. Arch Dis Child (1991) 1.68
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India. Eur Respir J (2011) 1.68
Non-linear phenomena in host-parasite interactions. Parasitology (1989) 1.67
Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer (2002) 1.67
Embryonic neural retinal cell response to extracellular matrix proteins: developmental changes and effects of the cell substratum attachment antibody (CSAT). J Cell Biol (1987) 1.67
Volatile and organic compositions of sedimentary rocks in Yellowknife Bay, Gale crater, Mars. Science (2013) 1.65
Slow coronary flow--a cause for angina with ST segment elevation and normal coronary arteries. A case report. Int J Cardiol (1998) 1.64
Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother (2000) 1.64
Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch Biochem Biophys (2000) 1.63
The neurogenetics of mucolipidosis type IV. Neurology (2002) 1.62
Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage. AJR Am J Roentgenol (1998) 1.62
Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol (2005) 1.62
Computed tomography in abdominal tuberculosis. Br J Radiol (1999) 1.60
Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol (1999) 1.60
Enzyme distribution along the nephron. Kidney Int (1984) 1.60